BACKLOG - Bridging the Appointments backlog, post COVID-19 through re-LOcation of urban and rural clinical service delivery
BACKLOG - Bridging the Appointments backlog, post COVID-19 through re-LOcation of urban and rural clinical service delivery
批准号:
63470
负责人:
金额:
$9.49万
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
中文摘要
积压将产生一个安全的基于云的地理空间(位置、距离和运输)上下文感知的资源和预约分配决策支持服务,以帮助NHS和公共卫生服务提供商安全有效地清除由于COVID-19危机而产生的门诊和小型干预措施积压。由于服务负责人可用的传统预约安排系统没有考虑到针对COVID-19应对措施提供的短期、第三方和移动资源,因此安排和管理积压的工作非常复杂。调度系统也没有考虑到病人的分离、“干净”诊所的可用性和病人的流动性。积压系统将把地点分配模型集成到现有的IT预约和调度(ERP)系统中,并将通过提高医生和患者的安全性、减少潜在的COVID-19接触点来影响他们;允许安全有效地减少患者积压,确保有效地优先处理病例。这将给社区一种恢复正常的感觉,因为它能够照常开展业务,确保恢复正常不会增加道路和医院的交通流量,确保所有病人都有足够的间隔,并通过寻找可能更近或可通过公共交通到达的预约来减少环境二氧化碳。一旦取消与COVID-19相关的限制,将通过支持重建皇家帕普沃斯医院的血氧仪诊断服务来检验积压工作的有效性。通常,在社区进行10,000多次血氧饱和度测试。自2020年3月19日暂停提供常规服务以来,积压的检测数量以每周195次或每月868次的速度增长。这项服务的目标是将睡眠服务预约的等候名单减少25%,并将多余的等候名单减少4个月。补充段落,解释“扩大影响”供资的影响:“扩大影响”供资将在若干方面支持项目的成功,预计将产生以下影响:两个主要影响是:a)降低实现预期项目影响的风险;b)扩大范围,提供更多与健康有关的服务,以便从服务优化工具中受益。更具体地说,这笔资金将导致:•更广泛的利益攸关方基础的参与利用项目的产出,扩大利益攸关方在医疗保健提供者以及其他服务(如公共卫生服务、制药试验组织)之间的参与和测试,这些服务同样需要有效修改服务地点/分配方案。更广泛的验证和改进机会确定新的市场利基和更广泛的定位机会更广泛的健康相关服务将受益于服务优化工具(节省资源和时间,以及防止因服务中断而导致的健康结果恶化)•付款人更有可能接受结果改进业务模式,并可能确定一种以上可行的业务模式;立足于更广泛的利益相关者基础,这一基础具有更广泛的潜在支付者(即不仅仅是NHS/ ccg),从而减轻了在使公共资金来源紧张的情况下吸收结果的风险。避免工具成功依赖于一个资金来源,并确保用于工具开发的公共资源不会被浪费,从而确保所承诺的影响将使社区受益。•弥合“死亡之谷”通过扩大和加速在更广泛的范围内传播和参与活动,缩短“死亡之谷”商业化阶段的持续时间和相关风险。有机会采取有效措施确保公司在一段时间内(例如1-2年)的生存能力,直到工具成为可信赖的产品。•初创企业的形成和加速cma和ILS将分拆活动,重点是推出积压工具,为市场渗透和投资者推销建立可识别的品牌标识。
英文摘要
BACKLOG will produce a secure cloud-based geospatial (location, distance, and transport) context aware resource and appointment allocation decision support service to aid the NHS and public health service providers safely and effectively clear the backlog of outpatient and small interventions which have occurred due to the COVID-19 crisis. The complexity of scheduling and managing this backlog is immense as the traditional appointment scheduling systems available to service leaders do not take into account the short-term, third-party, and mobile resources being made available in light of the COVID-19 response. The scheduling systems also do not take into account patient separation, availability of "clean" clinics, and the mobility of the patients. The BACKLOG system will integrate location-allocation models to the existing IT appointment and scheduling (ERP) systems and will impact medical practitioners and patients by improving their safety, reducing the potential COVID-19 touch points; allowing for a safe and efficient reduction in the patient backlog ensuring effective prioritisation of cases. This will give communities a sense of returning to normality by being able to carry on business as usual, ensuring the return to normality does not increase road and hospital traffic, by ensuring all patients are sufficiently spaced and will reduce environmental CO2 by finding appointments that may be closer or accessible via public transport.The effectiveness of BACKLOG will be tested by supporting the reestablishment of the Royal Papworth Hospital's oximetry diagnostics services once COVID-19 related restrictions are lifted. Typically, more than 10,000 oximetry tests are carried out in the community. Since routine service provision was suspended on 19th March 2020 the backlog of tests is growing by 195 a week or 868 a month. BACKLOG will aim to reduce the waiting list of sleep services appointments by 25% and the time to eliminate the excess waiting list by 4 months.Additional paragraph, explaining the effects of the “extension for Impact” funding: The “extension for impact” funding would support the success of the project in several ways and is expected to have the following effects:The two main effects are a) de-risking of achieving the expected project impacts and b) upscaling to a wider range of health-related services to benefit from service optimisation tools.More specifically, the funding will result in: • Engagement of wider stakeholder baseLeveraging the output of the project to scale up stakeholder engagement and testing across health care providers but also other services (e.g. public health services, pharmaceutical trial organisations), which encounter the same requirements for effective modifications of the service location / allocation options.Wider validation and refinement opportunitiesIdentification of new market niches and wider positioning opportunitiesA wider range of health-related services will benefit from service optimisation tools (savings of resource and time, as well as prevention of deterioration of health outcomes due to disruption of services) • Increased likelihood for uptake of results by a payerRefinement of the business model and possibly identification of more than one viable business models, stepping on a wider stakeholder base, which has a wider range of potential payers (i.e. not just the NHS/ CCGs), thus mitigating risks to the uptake of results in a situation, which strains public financing sources.Avoiding dependence of tool success on one funding source and securing that public resource spent on the tool development will not be wasted, thus ensuring that the promised impact will benefit the community. • Bridging the “valley of death”Decrease the duration and the associated risks of the “valley of death” phase of commercialisation by scaling up and acceleration of dissemination and engagement activities to wider circles.Opportunity to take effective measures to ensure viability of the company for a period (e.g. 1-2 years) until tool established as a trusted product. • Start-up formation and accelerationCMA and ILS will spin off the activities that will focus on the launch of the BACKLOG toolBuilding of a recognizable brand identity for market penetration and investor pitching.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金